Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden

被引:44
作者
Couturaud, Francis
Kearon, Clive
Leroyer, Christophe
Mercier, Bernard
Abgrall, Jean Francois
Le Gal, Grgoire
Lacut, Karine
Oger, Emmanuel
Bressollette, Luc
Ferec, Claude
Lamure, Michel
Mottier, Dominique
机构
[1] GETBO, Dept Internal Med & Chest Dis, Brest, France
[2] Transfus Ctr, Brest, France
[3] Dept Stat, Lyon, France
[4] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[5] Henderson Res Ctr, Hamilton, ON, Canada
关键词
familial thrombosis; venous thrombosis; factor V Leiden;
D O I
10.1160/TH06-06-0328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The factor V Leiden (FVL) mutation, a genetic abnormality with an autosomal mode of inheritance, is associated with an increased risk of venous thromboembolism (VTE). We aimed to determine the annual incidence of VTE in first-degree relatives of patients with VTE and FVL and to identify factors in patients and the relatives that influence this incidence. In this retrospective and prospective cohort study, the incidence of objectively diagnosed first episodes of VTE was assessed in 553 first-degree relatives of 161 patients with acute VTE and FVL. The annual incidence of VTE was 0.43% (95% Cl, 0.3 to 0.56) with FVL and 0.17% (95% Cl, 0.07 to 0.27) without FVL (relative risk of 2.5,95% Cl, 1.3 to 4.7). A majority (70%) of episodes of VTE were provoked, and this proportion was similar with and without FVL. A larger proportion of VTE was provoked in women (83%) that in men (33%),with the difference accounted for by pregnancy and use of oral contraceptives. The proportion of pregnancies complicated by VTE was 3.9% (95% Cl, 2.0-5.8) with FVL and 1.4% (95% Cl, 0.04-2.7) without FVL. FVL is associated with a two- to threefold increase in VTE in first-degree relatives of patients with VTE. No subgroup of relatives was identified who require more than routine prophylaxis because of a particularly high risk of VTE.
引用
收藏
页码:744 / 749
页数:6
相关论文
共 30 条
[21]   MUTATION IN THE GENE CODING FOR COAGULATION-FACTOR-V AND THE RISK OF MYOCARDIAL-INFARCTION, STROKE, AND VENOUS THROMBOSIS IN APPARENTLY HEALTHY-MEN [J].
RIDKER, PM ;
HENNEKENS, CH ;
LINDPAINTER, K ;
STAMPFER, MJ ;
EISENBERG, PR ;
MILETICH, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :912-917
[22]   Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation [J].
Ridker, PM ;
Glynn, RJ ;
Miletich, JP ;
Goldhaber, SZ ;
Stampfer, MJ ;
Hennekens, CH .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (07) :528-531
[23]   FACTOR-V LEIDEN AND RISKS OF RECURRENT IDIOPATHIC VENOUS THROMBOEMBOLISM [J].
RIDKER, PM ;
MILETICH, JP ;
STAMPFER, MJ ;
GOLDHABER, SZ ;
LINDPAINTNER, K ;
HENNEKENS, CH .
CIRCULATION, 1995, 92 (10) :2800-2802
[24]   Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism [J].
Ridker, PM ;
Goldhaber, SZ ;
Danielson, E ;
Rosenberg, Y ;
Eby, CS ;
Deitcher, SR ;
Cushman, M ;
Moll, S ;
Kessler, CM ;
Elliott, CG ;
Paulson, R ;
Wong, T ;
Bauer, KA ;
Schwartz, BA ;
Miletich, JP ;
Bounameaux, H ;
Glynn, RJ ;
Ridker, PM ;
Glynn, RJ ;
Danielson, EM ;
Bates, D ;
Christen, W ;
DeFonce, P ;
Griffin, W ;
Jackson, F ;
Murray, A ;
Taylor, K ;
Johnson, K ;
McKenna, K ;
Pierre, J ;
Holman, B ;
Dessources, F ;
Quinn, P ;
Laurinaitis, T ;
MacFadyen, J ;
Eby, C ;
Miletich, JP ;
Porche-Sorbet, R ;
Goldhaber, SZ ;
Morrison, RB ;
MacDougall, RC ;
Morrison, RM ;
Lamas, G ;
Bailey, K ;
Gersh, B ;
Pellegrino, E ;
Rick, M ;
Vaughan, D ;
Rosenberg, Y ;
Goldhaber, SZ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (15) :1425-1434
[25]   HIGH-RISK OF THROMBOSIS IN PATIENTS HOMOZYGOUS FOR FACTOR-V LEIDEN (ACTIVATED PROTEIN-C RESISTANCE) [J].
ROSENDAAL, FR ;
KOSTER, T ;
VANDENBROUCKE, JP ;
REITSMA, PH .
BLOOD, 1995, 85 (06) :1504-1508
[26]   The risk of recurrent venous thromboembolism in patients with an Arg(506)->Gln mutation in the gene for factor V (factor V Leiden) [J].
Simioni, P ;
Prandoni, P ;
Lensing, AWA ;
Scudeller, A ;
Sardella, C ;
Prins, MH ;
Villalta, S ;
Dazzi, F ;
Girolami, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (06) :399-403
[27]   Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study [J].
Simioni, P ;
Tormene, D ;
Prandoni, P ;
Zerbinati, P ;
Gavasso, S ;
Cefalo, P ;
Girolami, A .
BLOOD, 2002, 99 (06) :1938-1942
[28]   Incidence of venous thromboembolism in families with inherited thrombophilia [J].
Simioni, P ;
Sanson, BJ ;
Prandoni, P ;
Tormene, D ;
Friederich, PW ;
Girolami, B ;
Gavasso, S ;
Huisman, MV ;
Büller, HR ;
ten Cate, JW ;
Girolami, A ;
Prins, MH .
THROMBOSIS AND HAEMOSTASIS, 1999, 81 (02) :198-202
[29]   Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT) [J].
Vossen, CY ;
Conard, J ;
Fontcuberta, J ;
Makris, M ;
Van der Meer, FJM ;
Pabinger, I ;
Palareti, G ;
Preston, FE ;
Scharrer, I ;
Souto, JC ;
Svensson, P ;
Walker, ID ;
Rosendaal, FR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (03) :459-464
[30]  
VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753